Incomplete Kawasaki disease with multivessel giant coronary aneurysms and refractory thrombosis in an infant; a case report

Earlier diagnosis and risk-stratified therapy are essential to mitigate CAA complications. When revascularization and thrombolysis are not feasible or unsuccessful, individualized combinations of double antiplatelet and anticoagulant therapy may reduce thrombotic risk, necessitating close multidisciplinary follow-up.